Multiple sclerosis journal - experimental, translational and clinical

2026

Comorbidities in newly diagnosed multiple sclerosis patients: A population-based register study in Finland.

doi:10.1177/20552173251411076 ·PMID:41552666

BackgroundComorbidities are common among people with multiple sclerosis (pwMS) and have been suggested to affect the usage of disease-modifying treatments (DMTs).ObjectivesWe investigated the prevalence and types of comorbidities in newly d…

2024

A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab.

doi:10.1177/20552173241252566 ·PMID:38807848

BackgroundFatigue is the most debilitating symptom in patients with multiple sclerosis (MS). Natalizumab and rituximab are the most used MS disease modifying therapies in Sweden, but comparative data on the effect on fatigue is sparse.Objec…

2022

Trans-anal irrigation in patients with multiple sclerosis: Efficacy in treating disease-related bowel dysfunctions and impact on the gut microbiota: A monocentric prospective study.

doi:10.1177/20552173221109771 ·PMID:35832690

BackgroundConstipation and faecal incontinence are not so uncommon in patients with multiple sclerosis, impairing quality of life. The gut microbiota is altered in multiple sclerosis patients and likely contributes to disease pathogenesis. …

2021

The road to conception for women with multiple sclerosis.

doi:10.1177/20552173211032313 ·PMID:34350028

ObjectiveThe objective of this prospective "real world" study is to gain insight into the different "roads to conception" that women with MS take as part of the prospective Canadian Multiple Sclerosis Pregnancy Study (CANPREG-MS).MethodsPar…